Eventide Asset Management - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 158 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2015$2,721,000
-49.1%
482,5000.0%0.16%
-45.5%
Q2 2015$5,351,000
-29.3%
482,5000.0%0.29%
-49.0%
Q1 2015$7,566,000
+3.1%
482,5000.0%0.57%
-29.0%
Q4 2014$7,339,000
+41.0%
482,5000.0%0.80%
+10.2%
Q3 2014$5,204,000
-29.4%
482,5000.0%0.73%
-27.4%
Q2 2014$7,368,000
-11.9%
482,500
+4.3%
1.00%
-22.8%
Q1 2014$8,362,000
+177.1%
462,500
+112.8%
1.30%
+39.6%
Q4 2013$3,018,000217,3000.93%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q2 2015
NameSharesValueWeighting ↓
RA Capital Management 6,000,000$66,540,0006.69%
FIC CAPITAL INC 787,529$8,734,0003.47%
RA Capital Management 1,220,209$13,532,0001.36%
PRINCETON CAPITAL MANAGEMENT INC 114,120$1,266,0000.67%
Perceptive Advisors 800,000$8,872,0000.53%
Cormorant Asset Management, LP 361,000$4,003,0000.53%
Highlander Capital Management, LLC 43,500$482,0000.43%
APEX CAPITAL, LLC 439,900$4,878,0000.42%
WASATCH ADVISORS LP 3,091,386$34,283,0000.37%
Baker Brothers Advisors 3,230,932$35,831,0000.31%
View complete list of SANGAMO THERAPEUTICS INC shareholders